PROGNOSTIC CRITERIA FOR THE RISK OF BRONCHIAL ASTHMA IN CHILDREN WITH OBSTRUCTIVE BRONCHITIS

Authors:

Abstract:

The purpose of the study was to identify prognostic criteria for the formation of bronchial asthma in children with obstructive bronchitis. The material for the work included the data of a retrospective examination of 100 children with recurrent obstructive bronchitis aged from 1 to 7 years (the first group). The second group included 89 children diagnosed with bronchial asthma. All children underwent a comprehensive examination, including the copying of information from medical records, questioning of parents, analysis of risk factors, assessment of allergic history and examination of laboratory parameters. The diagnostic test for the absolute number of eosinophils showed high specificity of 84.9±4.9, and sensitivity of 63.6±14.5. The relative number of eosinophils showed high sensitivity and specificity: 81.8±5.2 and 84.1±4.0, respectively. Testing of immunoglobulin E showed absolute sensitivity of 100.0±0.0, specificity 72.2±7.5. Thus, high prognostic efficiency in the development of asthma in children with obstructive bronchitis has parental allergic diseases, urogenital infections and maternal preeclampsia during pregnancy, birth injury and asphyxia in the neonatal period, absolute and relative eosinophilia, hyperimmunoglobulinemia E.

Keywords:

bronchial asthma eosinophilia hyperimmunoglobulinemia E predictive indices

References:

1. Arron JR, Izuhara K. Asthma biomarkers: what constitutes a 'gold standard'? Thorax. 2015 Feb;70(2):105-7. doi: 10.1136/thoraxjnl-2014-206069. Epub 2014 Nov 28. PMID: 25432945.
2. Avramenko Y, Izmailova O, Shlykova O, Kaidashev I. Interleukin-26 is associated with the level of systemic inflammation and lung functions in obese and non-obese moderate-to-severe asthmatic patients. Adv Respir Med. 2022 Jan 27. doi: 10.5603/ARM.a2022.0006.
3. Chiappori A, De Ferrari L, Folli C, Mauri P, Riccio AM, Canonica GW. Biomarkers and severe asthma: a critical appraisal. Clin Mol Allergy. 2015 Oct 1; 13:20. doi: 10.1186/s12948-015-0027-7. PMID: 26430389; PMCID: PMC4590266.
4. Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019 Jun 18; 7:246. doi: 10.3389/fped.2019.00246.
5. Global Strategy for Asthma Management and Prevention. Global initiative for Asthma. 2020. 130 р. http://ginasthma.org/2020-gina-report-global-strategy-for-asthma-management-and-prevention.
6. Hastie AT, Moore WC, Li H, Rector BM, Ortega VE, Pascual RM, et al. National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol. 2013 Jul;132(1):72–80. doi: 10.1016/j.jaci.2013.03.044.
7. Kim H, Ellis AK, Fischer D, Noseworthy M, Olivenstein R, Chapman KR, et al. Asthma biomarkers in the age of biologics. Allergy, Asthma & Clinical Immunology. 2017; 13:48–65.
8. Lommatzsch M, Virchow JC. Severe asthma: definition, diagnosis and treatment. Dtsch Arztebl Int. 2014 Dec 12 ;111(50): 847–55. doi: 10.3238/arztebl.2014.0847.
9. Martinez FD, Vercelli D. Asthma. Lancet. 2013 Oct 19;382(9901):1360–72. doi: 10.1016/S0140-6736(13)61536-6.
10. Mims JW. Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol. 2015; 5,1: 2–6. doi: 10.1002/alr.21609.
11. O'Toole J, Mikulic L, Kaminsky DA. Epidemiology and Pulmonary Physiology of Severe Asthma. Immunol Allergy Clin North Am. 2016 Aug;36(3):425–38. doi: 10.1016/j.iac.2016.03.001.
12. Porpodis K, Tsiouprou I, Apostolopoulos A, Ntontsi P, Fouka E, Papakosta D. Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice. J Pers Med. 2022 Jun 30;12(7):1093. doi: 10.3390/jpm12071093.
13. Usemann J, Xu B, Delgado-Eckert E, Korten I, Anagnostopoulou P, Gorlanova O. Dynamics of respiratory symptoms during infancy and associations with wheezing at school age. ERJ Open Res. 2018 Nov 20;4(4):00037–2018.
14. doi: 10.1183/23120541.00037-2018.
15. Uwaezuoke SN, Ayuk AC, Eze JN. Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease. J Asthma Allergy. 2018 Jan 15; 11:11-18. doi: 10.2147/JAA.S149577.
16. Zhang XY, Simpson JL, Powell H, Yang IA, Upham JW, Reynolds PN. Full blood count parameters for the detection of asthma inflammatory phenotypes. Clin Exp Allergy. 2014 Sep;44(9):1137-45. doi: 10.1111/cea.12345.

Publication:

«World of Medicine and Biology» Vol. 18 No. 81 (2022) , с. 127-132
УДК 616.248-056.3-097-053.2

DOI:

https://doi.org/10.26724/2079-8334-2022-3-81-127-132